AtriCure ATRC
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$11.29M (3 inflow days, 17 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 40.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 7.71% to 9.61% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +3,362,936 | 15.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +738,818 | 4.2% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +499,801 | 7.1% |
| Principal Global Investors, LLC | Mutual Fund | 2026/Q3 | +316,382 | 0.8% |
| Loomis, Sayles & Company L.P. | Mutual Fund | 2026/Q3 | +313,506 | 0.6% |
| Public Sector Pension Investment Board | Government Pension Fund | 2026/Q3 | +259,000 | 0.5% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +162,986 | 0.4% |
| BNY Mellon Asset Management | Mutual Fund | 2026/Q3 | +114,210 | 0.5% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +94,971 | 0.7% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +1,018,527 | 2.5% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +604,380 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +431,867 | 8.8% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +424,563 | 6.1% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +353,615 | 1.1% |
| Hudson River Trading LLC | Private Company | 2026/Q3 | +232,665 | 0.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 5 Nov 2026 | B. Johnson | Independent Director | Open Market Disposition | -2,452 | $58.48 | 53,502 |
| 3 Nov 2026 | Salvatore Privitera | Chief Technology Officer | Automatic Disposition | -8,404 | $65.00 | 134,341 |
| 22 Sep 2026 | Salvatore Privitera | Chief Technology Officer | Automatic Disposition | -4,519 | $60.00 | 142,745 |
| 10 Sep 2026 | Regina Groves | Independent Director | Open Market Disposition | -5,313 | $54.22 | 34,546 |
| 9 Sep 2026 | Regina Groves | Independent Director | Intent to Sell (Form 144) | -5,313 | $53.66 | – |
| 7 Sep 2026 | Salvatore Privitera | Chief Technology Officer | Automatic Disposition | -3,657 | $55.00 | 147,264 |
| 1 Sep 2026 | Salvatore Privitera | Chief Technology Officer | Automatic Disposition | -7,763 | $52.50 | 150,921 |
| 23 Aug 2026 | Karl Dahlquist | Chief Legal Officer | Open Market Disposition | -9,370 | $48.89 | 87,319 |
| 4 Aug 2026 | Karen Prange | Independent Director | Open Market Disposition | -3,564 | $38.80 | 22,809 |
| 4 Aug 2026 | Maggie Yuen | Independent Director | Open Market Disposition | -3,500 | $38.42 | 14,015 |
| 29 Jul 2026 | Michael Carrel | Chief Executive Officer | Other Disposition | -4,700 | – | 792,694 |
| 28 Jul 2026 | Justin Noznesky | Chief Marketing & Strategy Officer | Open Market Disposition | -6,182 | $38.80 | 100,219 |
| 27 Jul 2026 | Sven Wehrwein | Independent Director | Derivative Exercise and Sale | -25,000 | $37.84 | 40,518 |
| 27 Jul 2026 | Vinayak Doraiswamy | Chief Scientific Officer | Open Market Disposition | -6,000 | $38.88 | 86,511 |
| 29 Jun 2026 | Michael Carrel | Chief Executive Officer | Other Acquisition | +636 | $23.78 | 796,694 |
| 29 Jun 2026 | Salvatore Privitera | Chief Technology Officer | Other Acquisition | +636 | $23.78 | 158,684 |
| 29 Jun 2026 | Douglas Seith | Chief Operating Officer | Other Acquisition | +527 | $23.78 | 229,867 |
| 29 Jun 2026 | Karl Dahlquist | Chief Legal Officer | Other Acquisition | +636 | $23.78 | 96,689 |
| 29 Jun 2026 | Vinayak Doraiswamy | Chief Scientific Officer | Other Acquisition | +636 | $23.78 | 92,511 |
| 19 May 2026 | Karen Prange | Independent Director | Open Market Disposition | -3,000 | $28.65 | 26,373 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 4,889,793 | 9.6% | 7.6 |
| 15 Oct 2026 | 4,886,394 | 9.6% | 5.2 |
| 30 Sep 2026 | 4,818,782 | 9.5% | 2.6 |
| 15 Sep 2026 | 4,279,518 | 8.4% | 3.6 |
| 31 Aug 2026 | 4,141,306 | 8.1% | 5.8 |
| 14 Aug 2026 | 3,922,615 | 7.7% | 6.1 |
No comments yet — be the first to weigh in on ATRC.
Sign in to join the discussion.